Defects of genes encoding inhibitors of coagulation and their application in early miscarriage aetiology
Properly functioning coagulation in gravidity is not necessary only to provide the continuity of circulation in placenta. Today we recognize that proteins and cells of haemostasis in the maternal blood cooperate with the components of a coagulation cascade produced by embryonic trophoblast cells. Su...
Gespeichert in:
Veröffentlicht in: | Bratislava Medical Journal 2014, Vol.115 (11), p.730-735 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 735 |
---|---|
container_issue | 11 |
container_start_page | 730 |
container_title | Bratislava Medical Journal |
container_volume | 115 |
creator | Simonidesova, M Simko, J Holoman, K |
description | Properly functioning coagulation in gravidity is not necessary only to provide the continuity of circulation in placenta. Today we recognize that proteins and cells of haemostasis in the maternal blood cooperate with the components of a coagulation cascade produced by embryonic trophoblast cells. Such coordination on the embryomaternal interface is necessary for an intact embryogenesis. Other findings discuss the ability of coagulation components to act also outside the hemocoagulation process, especially as signal molecules, regulators of immune reactions, cell proliferation and others. Haemostasis is thus a complex system and we still do not know all of its pathways. This is perhaps also the reason that in the case of known procoagulant mutations (FV Leiden, gene mutation for prothrombine G20210A) we cannot explain why some carriers suffer recurrent miscarriages and others have uncomplicated pregnancies. The expert community believes that the phenotype manifestation of these mutations in terms of pregnancy losses could be connected to the simultaneous presence (synergistic effect) of other polymorphisms of gene-encoding proteins of haemostasis or the lack thereof (antagonistic effect) (Ref. 59). |
doi_str_mv | 10.4149/BLL_2014_141 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1628880994</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1628880994</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-ee939913d28133d977838a7c861207e25a8aeb6971c4d2896e94e4fc7504c4b93</originalsourceid><addsrcrecordid>eNpNkD1PwzAQhi0EglLYmJFHBgL-imOPUD6lSCwwW45zSY3SONjp0H9PSgtiOuneR6_uHoQuKLkRVOjb-7I0jFBhqKAHaEY5lxnhIj9EM0KIzDQT6gSdpvRJiOA5lcfohOWCqVyIGVo-QANuTDg0uIUeEobehdr3Lfb90ld-DPEndMG2686OPvTY9jUel-AjtsPQebfb-h6Djd0Gr3xyNkZvW8AWpqwL7eYMHTW2S3C-n3P08fT4vnjJyrfn18VdmTmeyzED0Fxrymumpk9qXRSKK1s4JSkjBbDcKguV1AV1YmK0BC1ANK7IiXCi0nyOrna9Qwxfa0ij2Z4DXWd7COtkqGRKKaK1mNDrHepiSClCY4boVzZuDCVm69b8dzvhl_vmdbWC-g_-lcm_AYbddSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1628880994</pqid></control><display><type>article</type><title>Defects of genes encoding inhibitors of coagulation and their application in early miscarriage aetiology</title><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ)</source><creator>Simonidesova, M ; Simko, J ; Holoman, K</creator><creatorcontrib>Simonidesova, M ; Simko, J ; Holoman, K</creatorcontrib><description>Properly functioning coagulation in gravidity is not necessary only to provide the continuity of circulation in placenta. Today we recognize that proteins and cells of haemostasis in the maternal blood cooperate with the components of a coagulation cascade produced by embryonic trophoblast cells. Such coordination on the embryomaternal interface is necessary for an intact embryogenesis. Other findings discuss the ability of coagulation components to act also outside the hemocoagulation process, especially as signal molecules, regulators of immune reactions, cell proliferation and others. Haemostasis is thus a complex system and we still do not know all of its pathways. This is perhaps also the reason that in the case of known procoagulant mutations (FV Leiden, gene mutation for prothrombine G20210A) we cannot explain why some carriers suffer recurrent miscarriages and others have uncomplicated pregnancies. The expert community believes that the phenotype manifestation of these mutations in terms of pregnancy losses could be connected to the simultaneous presence (synergistic effect) of other polymorphisms of gene-encoding proteins of haemostasis or the lack thereof (antagonistic effect) (Ref. 59).</description><identifier>ISSN: 0006-9248</identifier><identifier>ISSN: 1336-0345</identifier><identifier>EISSN: 1336-0345</identifier><identifier>DOI: 10.4149/BLL_2014_141</identifier><identifier>PMID: 25428544</identifier><language>eng</language><publisher>Slovakia</publisher><subject>Abortion, Habitual - genetics ; Factor V - genetics ; Female ; Gene Expression Regulation, Enzymologic - genetics ; Humans ; Pregnancy ; Pregnancy Complications, Hematologic - genetics ; Pregnancy Trimester, First - genetics ; Pregnancy, High-Risk - genetics ; Risk Factors</subject><ispartof>Bratislava Medical Journal, 2014, Vol.115 (11), p.730-735</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25428544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simonidesova, M</creatorcontrib><creatorcontrib>Simko, J</creatorcontrib><creatorcontrib>Holoman, K</creatorcontrib><title>Defects of genes encoding inhibitors of coagulation and their application in early miscarriage aetiology</title><title>Bratislava Medical Journal</title><addtitle>Bratisl Lek Listy</addtitle><description>Properly functioning coagulation in gravidity is not necessary only to provide the continuity of circulation in placenta. Today we recognize that proteins and cells of haemostasis in the maternal blood cooperate with the components of a coagulation cascade produced by embryonic trophoblast cells. Such coordination on the embryomaternal interface is necessary for an intact embryogenesis. Other findings discuss the ability of coagulation components to act also outside the hemocoagulation process, especially as signal molecules, regulators of immune reactions, cell proliferation and others. Haemostasis is thus a complex system and we still do not know all of its pathways. This is perhaps also the reason that in the case of known procoagulant mutations (FV Leiden, gene mutation for prothrombine G20210A) we cannot explain why some carriers suffer recurrent miscarriages and others have uncomplicated pregnancies. The expert community believes that the phenotype manifestation of these mutations in terms of pregnancy losses could be connected to the simultaneous presence (synergistic effect) of other polymorphisms of gene-encoding proteins of haemostasis or the lack thereof (antagonistic effect) (Ref. 59).</description><subject>Abortion, Habitual - genetics</subject><subject>Factor V - genetics</subject><subject>Female</subject><subject>Gene Expression Regulation, Enzymologic - genetics</subject><subject>Humans</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Hematologic - genetics</subject><subject>Pregnancy Trimester, First - genetics</subject><subject>Pregnancy, High-Risk - genetics</subject><subject>Risk Factors</subject><issn>0006-9248</issn><issn>1336-0345</issn><issn>1336-0345</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkD1PwzAQhi0EglLYmJFHBgL-imOPUD6lSCwwW45zSY3SONjp0H9PSgtiOuneR6_uHoQuKLkRVOjb-7I0jFBhqKAHaEY5lxnhIj9EM0KIzDQT6gSdpvRJiOA5lcfohOWCqVyIGVo-QANuTDg0uIUeEobehdr3Lfb90ld-DPEndMG2686OPvTY9jUel-AjtsPQebfb-h6Djd0Gr3xyNkZvW8AWpqwL7eYMHTW2S3C-n3P08fT4vnjJyrfn18VdmTmeyzED0Fxrymumpk9qXRSKK1s4JSkjBbDcKguV1AV1YmK0BC1ANK7IiXCi0nyOrna9Qwxfa0ij2Z4DXWd7COtkqGRKKaK1mNDrHepiSClCY4boVzZuDCVm69b8dzvhl_vmdbWC-g_-lcm_AYbddSA</recordid><startdate>2014</startdate><enddate>2014</enddate><creator>Simonidesova, M</creator><creator>Simko, J</creator><creator>Holoman, K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2014</creationdate><title>Defects of genes encoding inhibitors of coagulation and their application in early miscarriage aetiology</title><author>Simonidesova, M ; Simko, J ; Holoman, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-ee939913d28133d977838a7c861207e25a8aeb6971c4d2896e94e4fc7504c4b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Abortion, Habitual - genetics</topic><topic>Factor V - genetics</topic><topic>Female</topic><topic>Gene Expression Regulation, Enzymologic - genetics</topic><topic>Humans</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Hematologic - genetics</topic><topic>Pregnancy Trimester, First - genetics</topic><topic>Pregnancy, High-Risk - genetics</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simonidesova, M</creatorcontrib><creatorcontrib>Simko, J</creatorcontrib><creatorcontrib>Holoman, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bratislava Medical Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simonidesova, M</au><au>Simko, J</au><au>Holoman, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Defects of genes encoding inhibitors of coagulation and their application in early miscarriage aetiology</atitle><jtitle>Bratislava Medical Journal</jtitle><addtitle>Bratisl Lek Listy</addtitle><date>2014</date><risdate>2014</risdate><volume>115</volume><issue>11</issue><spage>730</spage><epage>735</epage><pages>730-735</pages><issn>0006-9248</issn><issn>1336-0345</issn><eissn>1336-0345</eissn><abstract>Properly functioning coagulation in gravidity is not necessary only to provide the continuity of circulation in placenta. Today we recognize that proteins and cells of haemostasis in the maternal blood cooperate with the components of a coagulation cascade produced by embryonic trophoblast cells. Such coordination on the embryomaternal interface is necessary for an intact embryogenesis. Other findings discuss the ability of coagulation components to act also outside the hemocoagulation process, especially as signal molecules, regulators of immune reactions, cell proliferation and others. Haemostasis is thus a complex system and we still do not know all of its pathways. This is perhaps also the reason that in the case of known procoagulant mutations (FV Leiden, gene mutation for prothrombine G20210A) we cannot explain why some carriers suffer recurrent miscarriages and others have uncomplicated pregnancies. The expert community believes that the phenotype manifestation of these mutations in terms of pregnancy losses could be connected to the simultaneous presence (synergistic effect) of other polymorphisms of gene-encoding proteins of haemostasis or the lack thereof (antagonistic effect) (Ref. 59).</abstract><cop>Slovakia</cop><pmid>25428544</pmid><doi>10.4149/BLL_2014_141</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-9248 |
ispartof | Bratislava Medical Journal, 2014, Vol.115 (11), p.730-735 |
issn | 0006-9248 1336-0345 1336-0345 |
language | eng |
recordid | cdi_proquest_miscellaneous_1628880994 |
source | MEDLINE; Free E-Journal (出版社公開部分のみ) |
subjects | Abortion, Habitual - genetics Factor V - genetics Female Gene Expression Regulation, Enzymologic - genetics Humans Pregnancy Pregnancy Complications, Hematologic - genetics Pregnancy Trimester, First - genetics Pregnancy, High-Risk - genetics Risk Factors |
title | Defects of genes encoding inhibitors of coagulation and their application in early miscarriage aetiology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A16%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Defects%20of%20genes%20encoding%20inhibitors%20of%20coagulation%20and%20their%20application%20in%20early%20miscarriage%20aetiology&rft.jtitle=Bratislava%20Medical%20Journal&rft.au=Simonidesova,%20M&rft.date=2014&rft.volume=115&rft.issue=11&rft.spage=730&rft.epage=735&rft.pages=730-735&rft.issn=0006-9248&rft.eissn=1336-0345&rft_id=info:doi/10.4149/BLL_2014_141&rft_dat=%3Cproquest_cross%3E1628880994%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1628880994&rft_id=info:pmid/25428544&rfr_iscdi=true |